Summary
Cannot be evaluated against the FDA-approved prescribing information because no actual FDA label text for the product relevant to the claims (MONISTAT 7) was provided; the excerpts appear to be for MONISTAT 3. As a result, claim-by-claim alignment cannot be verified and may be materially inaccurate.
Category Scores
Accurate Statements
Unsupported Statements
Monistat 7 is an antifungal treatment for vaginal yeast infections.
Provided label excerpts are for MONISTAT 3 Vaginal Suppositories, not MONISTAT 7; no MONISTAT 7-specific indication text was provided to verify this claim.
The key active ingredient in Monistat 7 is miconazole nitrate.
No MONISTAT 7 active-ingredient section was provided in the label excerpts.
Miconazole nitrate is an antifungal.
While the excerpts state miconazole nitrate exhibits fungicidal activity in vitro against Candida, this does not confirm antifungal treatment claims for MONISTAT 7 specifically; MONISTAT 7-specific label context was not provided.
Monistat 7 products contain non-medicinal (inactive) ingredients.
No MONISTAT 7 inactive-ingredients/DrugeFacts listing was provided.
The inactive ingredients in Monistat 7 can vary by the exact Monistat 7 product type and package (for example, cream vs. suppositories).
No MONISTAT 7 inactive-ingredient variation statement was provided.
The most reliable way to get the exact ingredient list for a specific Monistat 7 package is to check the 'Inactive ingredients' section on that specific package.
No label text provided addresses this process as a reliability statement.
Monistat 7 may refer to different formats sold under the same brand name.
No label excerpts were provided that define 'Monistat 7' as multiple formats.
Active ingredients on Monistat 'Drug Facts' include miconazole nitrate.
No 'Drug Facts' MONISTAT 7 section was provided in the label excerpts.
Inactive ingredients on Monistat 'Drug Facts' are excipients used to make the cream or suppository.
No MONISTAT 7 'Drug Facts' inactive-ingredients explanation was provided.
Contradictions
Important Omissions
MONISTAT 7-specific FDA-approved label excerpts for indication, active ingredient strength, dosage/formulation, contraindications, warnings/precautions, and inactive ingredients were not provided; only MONISTAT 3 excerpts were included.
Importance:
High
Safety Assessment
Potential Patient Risk:
High
Claims about MONISTAT 7 (active ingredient, inactive ingredients, and format) cannot be verified against the provided label excerpts, which appear to be for MONISTAT 3. This creates a material risk of incorrect product-specific information.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Not Evaluatable
Primary Issue
Provided prescribing information excerpts are for MONISTAT 3, not MONISTAT 7, so MONISTAT 7-related claims cannot be verified.
Suggested Improvement
Provide FDA-approved prescribing information (or Drug Facts) specifically for MONISTAT 7 (including active ingredient strength, indication, and inactive ingredients list/section). Then evaluate each claim against those exact sections.